Pharmacoeconomic considerations in peripheral arterial thrombolytic therapy.

نویسنده

  • A F Kaul
چکیده

Intraarterial thrombolytic therapy with urokinase (UK) offers documented advantages to alternatives for treating both subacute and the initial presentation of acute peripheral arterial occlusion (PAO), including reduced morbidity and mortality. Treatment with intraarterial UK does not increase overall health care costs; hospital length of stay is either similar to that with other therapies (acute PAO) or is shortened (subacute PAO). Total hospital charges associated with use of intraarterial UK are also not significantly elevated. Thus, thrombolysis with UK offers both a clinically superior and a cost-beneficial way to treat PAO.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Limitations of CT Angiography in Patient Selection for Thrombolytic Therapy

Limitations of CT Angiography in Patient Selection for Thrombolytic Therapy To the Editor: We have read with great interest the article by Wildermuth et al1 on the role of CT angiography (CTA) in patient selection for thrombolytic therapy. The authors report that selection of patients with little potential for benefit from thrombolytic therapy is feasible with the use of CTA. The CTA findings, ...

متن کامل

Limitations of CT angiography in patient selection for thrombolytic therapy.

Limitations of CT Angiography in Patient Selection for Thrombolytic Therapy To the Editor: We have read with great interest the article by Wildermuth et al1 on the role of CT angiography (CTA) in patient selection for thrombolytic therapy. The authors report that selection of patients with little potential for benefit from thrombolytic therapy is feasible with the use of CTA. The CTA findings, ...

متن کامل

Thrombolytic Therapy.

The purpose of this communication is to review briefly the agents available at the present time for use in thrombolytic therapy and to indicate why we believe that at the present time streptokinase is the only suitable agent for extended clinical trial. An account will then be given of the use of streptokinase administered by local perfusion in the treatment of peripheral arterial occlusion and...

متن کامل

SCVIR reporting standards for the treatment of acute limb ischemia with use of transluminal removal of arterial thrombus.

ACUTE limb ischemia is any sudden decrease or worsening in limb perfusion that causes a potential threat to limb viability (1). Acute peripheral arterial occlusion may be caused by in situ thrombosis or embolus. In this article, the term “thrombus” will be used to describe arterial occlusion caused by in situ thrombosis or embolus. Percutaneous or “open” surgical techniques can be used to remov...

متن کامل

Economic implications of thrombolysis or operation as the initial treatment modality in acute peripheral arterial occlusion.

BACKGROUND Thrombolytic agents have been used to treat arterial occlusion for almost 40 years. Recently, an investigation of the costs associated with two treatment options for acute peripheral arterial occlusions, thrombolysis and surgical intervention, was completed. The availability of hospital cost data for patients enrolled in the thrombolytic and operative treatment groups provided a basi...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Journal of vascular and interventional radiology : JVIR

دوره 6 6 Pt 2 Suppl  شماره 

صفحات  -

تاریخ انتشار 1995